These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2510815)

  • 1. Study of three patients with monoclonal gammopathies and 'lupus-like' anticoagulants.
    Bellotti V; Gamba G; Merlini G; Montani N; Bucciarelli E; Stoppini M; Ascari E
    Br J Haematol; 1989 Oct; 73(2):221-7. PubMed ID: 2510815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lupus anticoagulant associated syndrome in benign and malignant systemic disease--analysis of ten observations.
    Dührsen U; Paar D; Kölbel C; Boekstegers A; Metz-Kurschel U; Wagner R; Kirch W; Meusers P; König E; Brittinger G
    Klin Wochenschr; 1987 Sep; 65(18):852-9. PubMed ID: 3118094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological specificity and mechanism of action of IgG lupus anticoagulants.
    Pengo V; Thiagarajan P; Shapiro SS; Heine MJ
    Blood; 1987 Jul; 70(1):69-76. PubMed ID: 3109526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal hybridoma anti-cardiolipin antibodies from SLE mice.
    Ichikawa K; Shimada K; Nawata Y; Ishii T; Tomioka H; Yoshida S; Koike T
    Clin Exp Immunol; 1988 Oct; 74(1):110-4. PubMed ID: 3146452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lupus anticoagulant. A report of 8 cases.
    Agarwal MB; Agarwal UM
    J Assoc Physicians India; 1991 Mar; 39(3):243-5. PubMed ID: 1908857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times.
    Alving BM; Barr CF; Tang DB
    Am J Med; 1990 Feb; 88(2):112-6. PubMed ID: 2105643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of lupus-like anticoagulants by an enzyme-linked immunosorbent assay using a partial thromboplastin as antigen; a comparative study.
    Arnout J; Huybrechts E; Vanrusselt M; Falcon C; Vermylen J
    Thromb Haemost; 1990 Aug; 64(1):26-31. PubMed ID: 2125756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyfunctional properties of hybridoma lupus anticoagulant antibodies.
    Rauch J; Tannenbaum H; Senécal JL; Janoff AS; Cullis PR; Frojmovic MM
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():132-7. PubMed ID: 3112375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of lupus like anticoagulant: current laboratory practice in the United Kingdom. The Lupus Anticoagulant Working Party.
    J Clin Pathol; 1990 Jan; 43(1):73-5. PubMed ID: 2107213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between lupus anticoagulants and antibodies to phospholipid.
    Triplett DA; Brandt JT; Musgrave KA; Orr CA
    JAMA; 1988 Jan 22-29; 259(4):550-4. PubMed ID: 3121871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupus anticoagulant in liver cirrhosis.
    Violi F; Ferro D; Valesini G; Quintarelli C; Balsano F
    Thromb Haemost; 1988 Apr; 59(2):335. PubMed ID: 3133815
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of various screening and confirmatory tests for the detection of the lupus anticoagulant.
    Forastiero RR; Falcón CR; Carreras LO
    Haemostasis; 1990; 20(4):208-14. PubMed ID: 2122955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic phenomena in the presence of a circulating anticoagulant.
    Quintero AL; Lugo-Somolinos A; Sánchez JL
    Bol Asoc Med P R; 1990 Oct; 82(10):444-7. PubMed ID: 2127888
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of lupus anticoagulants on the activated partial thromboplastin time. Results of the College of American Pathologists survey program.
    Brandt JT; Triplett DA; Rock WA; Bovill EG; Arkin CF
    Arch Pathol Lab Med; 1991 Feb; 115(2):109-14. PubMed ID: 1899555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory identification of the lupus anticoagulant.
    Triplett DA; Brandt J
    Br J Haematol; 1989 Oct; 73(2):139-42. PubMed ID: 2510814
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics.
    McNeil HP; Chesterman CN; Krilis SA
    Br J Haematol; 1989 Dec; 73(4):506-13. PubMed ID: 2514785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticardiolipin antibodies possess anticoagulant activity which is blocked by a monoclonal antibody against a cross reacting idiotype of antiphospholipid antibodies.
    Valesini G; Violi F; Ferro D; Quintarelli C; Falco M; Tincani A; Balestrieri G; Balsano F
    Clin Exp Rheumatol; 1989; 7(6):615-8. PubMed ID: 2515018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating coagulation inhibitors in the acquired immunodeficiency syndrome.
    Cohen AJ; Philips TM; Kessler CM
    Ann Intern Med; 1986 Feb; 104(2):175-80. PubMed ID: 3080933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A study on evaluation of circulating anticoagulant in borderline cases].
    Ishii K; Himizu M; Ono F; Yamamoto M; Kawai Y; Watanabe K; Iri H
    Rinsho Byori; 1989 Dec; 37(12):1379-84. PubMed ID: 2515324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relation of antiphospholipid antibodies to thrombotic phenomena and clinical activity of systemic lupus erythematosus].
    Font J; Cervera R; Casals FJ; Bové A; Guerrero A; López-Soto A; Ingelmo M; Urbano-Márquez A
    Med Clin (Barc); 1988 Mar; 90(12):490-3. PubMed ID: 3134583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.